These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 27147945)

  • 21. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
    Schifano F; Papanti GD; Orsolini L; Corkery JM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychostimulant Effect of the Synthetic Cannabinoid JWH-018 and AKB48: Behavioral, Neurochemical, and Dopamine Transporter Scan Imaging Studies in Mice.
    Ossato A; Uccelli L; Bilel S; Canazza I; Di Domenico G; Pasquali M; Pupillo G; De Luca MA; Boschi A; Vincenzi F; Rimondo C; Beggiato S; Ferraro L; Varani K; Borea PA; Serpelloni G; De-Giorgio F; Marti M
    Front Psychiatry; 2017; 8():130. PubMed ID: 28824464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Google Trends to monitor new psychoactive substance. Is there an added value?
    Batistic FK; Rhumorbarbe D; Lefrancois E; Tettey J; Raithelhuber M; Rossy Q; Morelato M
    Forensic Sci Int; 2021 Jul; 326():110918. PubMed ID: 34325112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases.
    Vaiano F; Busardò FP; Palumbo D; Kyriakou C; Fioravanti A; Catalani V; Mari F; Bertol E
    J Pharm Biomed Anal; 2016 Sep; 129():441-449. PubMed ID: 27490334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
    Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
    Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence.
    Barbieri M; Ossato A; Canazza I; Trapella C; Borelli AC; Beggiato S; Rimondo C; Serpelloni G; Ferraro L; Marti M
    Neuropharmacology; 2016 Oct; 109():254-269. PubMed ID: 27346209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.
    Palamar JJ; Su MK; Hoffman RS
    Am J Drug Alcohol Abuse; 2016; 42(1):39-47. PubMed ID: 26678258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical toxicology of newer recreational drugs.
    Hill SL; Thomas SH
    Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise.
    Catalani V; Corkery JM; Guirguis A; Napoletano F; Arillotta D; Zangani C; Vento A; Schifano F
    Eur Neuropsychopharmacol; 2021 Aug; 49():69-92. PubMed ID: 33857740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baths salts, spice, and related designer drugs: the science behind the headlines.
    Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
    J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal Poisonings Associated with New Psychoactive Substances.
    Kronstrand R; Guerrieri D; Vikingsson S; Wohlfarth A; Gréen H
    Handb Exp Pharmacol; 2018; 252():495-541. PubMed ID: 30105471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
    Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
    Front Psychiatry; 2020; 11():569. PubMed ID: 32733288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of analytical method for identification of new psychoactive substances using linear retention indexes and gas chromatography-mass spectrometry.
    Zacca JJ; Giudice GH; Souza MP; Caldas LNB; Vieira ML; Machado AHL
    J Chromatogr A; 2021 Jan; 1636():461783. PubMed ID: 33340744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulant and hallucinogenic novel psychoactive substances; an update.
    Schifano F; Vento A; Scherbaum N; Guirguis A
    Expert Rev Clin Pharmacol; 2023; 16(11):1109-1123. PubMed ID: 37968919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
    Tanda G; Goldberg SR
    Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.
    Panagis G; Vlachou S; Nomikos GG
    Curr Drug Abuse Rev; 2008 Nov; 1(3):350-74. PubMed ID: 19630731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Spice drugs: cannabinoids as a new designer drugs].
    Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
    Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and characterization of emerging psychoactive substances by ion mobility spectrometry.
    Armenta S; Garrigues S; de la Guardia M; Brassier J; Alcalà M; Blanco M; Perez-Alfonso C; Galipienso N
    Drug Test Anal; 2015 Apr; 7(4):280-9. PubMed ID: 24935207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances.
    Rodrigues CHP; Mariotto LS; Castro JS; Peruquetti PH; Silva-Junior NC; Bruni AT
    Forensic Toxicol; 2023 Jul; 41(2):187-212. PubMed ID: 36604359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of action of stimulant novel psychoactive substances that target the high-affinity transporter for dopamine.
    Sahai MA; Opacka-Juffry J
    Neuronal Signal; 2021 Dec; 5(4):NS20210006. PubMed ID: 34888062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.